BIOTIME, INC. 8-K 12-9-2015

Company

Lineage Cell Therapeutics, Inc.

Filed

December 15, 2015

Period of Report

December 9, 2015

Accession Number

0001140361-15-044510

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →